Search results
Results From The WOW.Com Content Network
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. [5] [6] [7] As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in ...
History [ edit ] Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology.
Ramesh C. Juneja (born 28 July 1955) is an Indian billionaire businessman and the Chairman of Mankind Pharma. [1] He is one of the 100 richest Indians as per Forbes ; [ 2 ] his net worth was estimated to be $2.3 billion in 2019.
Another of the Searle trust’s top beneficiaries is the State Policy Network, which has received nearly $9 million – in addition to other funds that went to individual organizations that ...
Pathkind Labs was set up in 2016. It is promoted by diagnostic industry veteran Sanjeev Vashishta and the promoters of Mankind Pharma. [4] Pathkind Diagnostics began its operations in August 2017 and currently operates in 20+ states in India. The company has a network of over 70 labs and more than 2000+ collection centers.
Lupin's South African subsidiary, Pharma Dynamics (PD) [35] is the fastest growing and the 4th largest generic company in the South African market (IMS). [ citation needed ] The company is a market leader in the Cardiovascular segment and has a growing presence in Neurology, Gastroenterology and the Over the Counter (OTC) segments.
For four seasons, Apple TV+'s For All Mankind has presented an alternate history of the space race, starting in a world where Russia, not America, put the first person on the moon. That single ...
The company's first international move took it to Russia in 1992. There, Dr. Reddy's formed a joint venture with the country's biggest pharmaceuticals producer, Biomed.They pulled out in 1995 amid accusations of scandal, involving "a significant material loss due to the activities of Moscow's branch of Reddy's Labs with the help of Biomed's chief executive". [8]